Profound Medical Corp. (NASDAQ:PROF) on Tuesday announced that Johns Hopkins Hospital has performed its first commercial prostate cancer treatment using the company's TULSA-PRO system, marking a key adoption milestone for the MRI-guided, incision-free ablation technology.
Bright Minds Biosciences (NASDAQ:DRUG) shares are under the spotlight following the announcement of "positive and significant" topline results from its Phase 2 BREAKTHROUGH study.
Alkermes (NASDAQ:ALKS) announced on January 6, 2026, that the U.S. FDA has granted Breakthrough Therapy Designation to alixorexton (formerly ALKS 2680) for the treatment of narcolepsy type 1 (NT1).
Sunoco LP (NYSE:SUN) issued its 2026 financial guidance on Tuesday, January 6, 2026, projecting a robust leap in earnings following a year of massive consolidation.
The partnership expects full-year adjusted EBITDA to land between $3.1 billion and $3.3 billion, a range that reflects the full integration of the Parkland acquisition and the upcoming close of the TanQuid terminal deal in Europe.
Ryder System (NYSE:R) announced the successful acquisition of Truck Service Depot, an Atlanta-based mobile maintenance firm, on January 5, 2026.
The move is a strategic bolt-on for Torque by Ryder™, the company’s rapidly expanding retail mobile maintenance division, as it seeks to capture a larger share of the on-demand fleet service market in the Southeast.
McEwen Mining (NYSE:MUX) and Canadian Gold Corp. completed their statutory plan of arrangement effective January 5, 2026, officially consolidating the high-grade Tartan Gold Mine into McEwen’s portfolio.
The merger, finalized at 8:00 a.m. Vancouver time, marks a strategic expansion for McEwen as it targets a doubling of its total production by 2030.
Apogee Therapeutics (NASDAQ:APGE) shares are trending today after the company reported positive interim Phase 1b results for zumilokibart (APG777), its half-life extended anti-IL-13 antibody.
Aclarion (NASDAQ:ACON) reached a significant clinical milestone on Tuesday, January 6, 2026, announcing the first patient enrollments at two prestigious new sites: Northwestern Medicine and Scripps Health.
This expansion brings the total number of active enrollment sites to four, with seven leading U.S. spine centers having completed full regulatory and operational setup.
Radware (NASDAQ:RDWR) announced Tuesday, January 6, 2026, that it has doubled its global cloud security mitigation capacity, jumping from 15 Tbps to 30 Tbps.
The massive upgrade comes in response to a "seismic shift" in the threat landscape, headlined by an 85% surge in network DDoS attacks during the first half of 2025.
Lithium Argentina AG (NYSE:LAR) shares are in focus after the company announced standout preliminary 2025 results for its Cauchari-Olaroz operation.
The project, a joint venture with Ganfeng Lithium, achieved full-year production of 34,100 tonnes of lithium carbonate—reaching the upper limit of its 30,000–35,000 tonne guidance.
AngioDynamics (NASDAQ:ANGO) on Tuesday reported fiscal second-quarter results that highlighted continued momentum in its high-margin Med Tech portfolio, with overall net sales rising 8.8% year over year to $79.4 million for the period ended Nov. 30, 2025.
Accenture (NYSE:ACN) has agreed to acquire Faculty, a prominent U.K.-based AI services and products firm, in a move that signals a major escalation in the global consulting giant's push toward "applied AI."
